The breadth and depth of our medical know-how enables us to provide strategic and organization support right across your asset portfolio – from molecule development to launch. At the heart of this support is our expertise, experience and evidence.

Expertise

Our medical affairs specialists have extensive experience in partnering with clients to develop medical strategies that unlock the full potential of your biopharma innovation. Our depth of expertise stretches across many therapeutic areas: oncology, haematology, immunology, neurosciences, infectious diseases and rare diseases. We combine this scientific understanding with business-minded thinking. From day one, we understand not only your molecule but its potential.

Experience

We have the medical, scientific and strategic experience needed to successfully partner with medical VPs and directors. We do so at both a portfolio planning and evidence-generation strategy level. With our depth of understanding, we can shape the organizational development required to unlock the full potential of your medical affairs capabilities. We’ll ensure you’re designed and constructed as a world-class medical affairs function – ready to guide the future of your organization.

Evidence

Evidence generation is at the forefront of our approach to ensure you achieve not just the regulatory criteria, but you also achieve access and successful commercialization. Our team is steeped in content knowledge to fuel key strategic discussions and ensure that disease nuances, mechanistic options and therapeutic trends are fully incorporated. We ensure that strategy is developed in the medical and scientific context to unlock the full potential of your innovation.